Custom treatment for high-risk forms of prostate cancer


There’s a long article by Ron Winslow in the Wall Street Journal today about the potential for “custom-treatment” of men with aggressive and less aggressive forms of high-risk prostate cancer.

While there is nothing inherently new in this article, it does give a “layman’s” perspective on how some groups of researchers are thinking about how to better manage men with higher-risk prostate cancers, based on the patients’ genetic/genomic profiles, such that one optimizes the effects of treatment while minimizing the need for over-treatment.

[Editorial note: Please note that we cannot guarantee that you will be able to see the full article if you are not a subscriber to the WSJ, although your sitemaster is not a subscriber and he was able to view the full text.]

2 Responses

  1. The WSJ attribution (byline) is “Ron Winslow”, rather than “Howard Ditto”. From outside the USA one is unaware of this journalist’s possible “a.k.a.s” ???

  2. Ooops. Typo. Mea culpa. Now corrected.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: